Antithyroideaantistof hos to patienter med subakut dementiel udvikling, ataksi og myoklonus
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Standard
Antithyroideaantistof hos to patienter med subakut dementiel udvikling, ataksi og myoklonus. / Kondziella, Daniel; Hansen, Klaus; Gonzalez, Teresa; Gideon, Peter; Christiansen, Ingelise; Sellebjerg, Finn.
I: Ugeskrift for Laeger, Bind 174, Nr. 9, 2012, s. 577-9.Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Antithyroideaantistof hos to patienter med subakut dementiel udvikling, ataksi og myoklonus
AU - Kondziella, Daniel
AU - Hansen, Klaus
AU - Gonzalez, Teresa
AU - Gideon, Peter
AU - Christiansen, Ingelise
AU - Sellebjerg, Finn
PY - 2012
Y1 - 2012
N2 - Hashimoto encephalitis (HE) is a steroid-responsive autoimmune encephalitis with anti-thyroid antibodies; Creutzfeldt-Jakob disease (CJD) is a prion disease. Both disorders can have a similar clinical presentation. Two women, 67 and 63 year-old, with subacute dementia, ataxia, myoclonus and positive antithyroid antibodies were given oral steroids. Whereas one progressively declined and had histopathologically proven CJD, the other made a complete recovery and was diagnosed with HE. Anti-thyroid antibodies can occur in CJD, but when present in a patient with subacute dementia, ataxia and myoclonus, a steroid trial always seems indicated.
AB - Hashimoto encephalitis (HE) is a steroid-responsive autoimmune encephalitis with anti-thyroid antibodies; Creutzfeldt-Jakob disease (CJD) is a prion disease. Both disorders can have a similar clinical presentation. Two women, 67 and 63 year-old, with subacute dementia, ataxia, myoclonus and positive antithyroid antibodies were given oral steroids. Whereas one progressively declined and had histopathologically proven CJD, the other made a complete recovery and was diagnosed with HE. Anti-thyroid antibodies can occur in CJD, but when present in a patient with subacute dementia, ataxia and myoclonus, a steroid trial always seems indicated.
M3 - Tidsskriftartikel
VL - 174
SP - 577
EP - 579
JO - Ugeskrift for Laeger
JF - Ugeskrift for Laeger
SN - 0041-5782
IS - 9
ER -
ID: 48459435